aporphine has been researched along with mdl 100907 in 1 studies
Studies (aporphine) | Trials (aporphine) | Recent Studies (post-2010) (aporphine) | Studies (mdl 100907) | Trials (mdl 100907) | Recent Studies (post-2010) (mdl 100907) |
---|---|---|---|---|---|
86 | 0 | 47 | 1,241 | 65 | 539 |
Protein | Taxonomy | aporphine (IC50) | mdl 100907 (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0048 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaudhary, S; Harding, WW; Legendre, O; Navarro, HA; Pecic, S | 1 |
1 other study(ies) available for aporphine and mdl 100907
Article | Year |
---|---|
(+/-)-Nantenine analogs as antagonists at human 5-HT(2A) receptors: C1 and flexible congeners.
Topics: Aporphines; Calcium; Carbon; Chemistry, Pharmaceutical; Drug Design; Humans; Inhibitory Concentration 50; Kinetics; Models, Chemical; Molecular Structure; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2009 |